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Abstract The L-subunit (E1L) of the pyruvate decarboxylase
(E1, K2L2) component of the Bacillus stearothermophilus pyru-
vate dehydrogenase complex was comparatively modelled based
on the crystal structures of the homologous 2-oxoisovalerate
decarboxylase of Pseudomonas putida and Homo sapiens.
Based on this homology modelling, alanine-scanning mutagene-
sis studies revealed that the negatively charged side chain of
Glu285 and the hydrophobic side chain of Phe324 are of partic-
ular importance in the interaction with the peripheral subunit-
binding domain of the dihydrolipoyl acetyltransferase compo-
nent of the complex. These results help to identify the site of
interaction on the E1L subunit and are consistent with thermo-
dynamic evidence of a mixture of electrostatic and hydrophobic
interactions being involved.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
In most organisms, the oxidative decarboxylation of pyru-
vate is performed by enzymes of the pyruvate dehydrogenase
(PDH) complex, which consists of pyruvate decarboxylase
(E1, EC 1.2.4.1), dihydrolipoyl acetyltransferase (E2, EC
2.3.1.12) and dihydrolipoyl dehydrogenase (E3, EC 1.8.1.4).
Multiple copies of the three enzymes are non-covalently, but
tightly, assembled into a highly organised multienzyme com-
plex. E1 catalyses both the thiamine diphosphate-dependent
decarboxylation of the pyruvate and the subsequent reductive
acetylation of a lipoyl group, which is covalently bound to the
E2. E2 catalyses the acyl transfer to CoA, and E3 the reox-
idation of the resulting dihydrolipoyl moiety with NADþ as
the ultimate electron acceptor (for reviews, see [1,2]).
E2 forms the structural core of the complex, composed of
24 or 60 E2 polypeptide chains organised with octahedral or
eicosahedral symmetry, respectively, according to the source.
The E2 chain has a multi-domain-and-linker structure. In the
eicosahedral Bacillus stearothermophilus PDH complex, it con-
sists of one lipoyl domain (LD), a peripheral subunit-binding
domain (PSBD), and an acetyltransferase inner core domain
(CD), which are connected by long and £exible linker seg-
ments rich in proline, alanine and charged amino acids [2,3].
The PSBD, located between the N-terminal LD and C-termi-
nal CD, is remarkably small (only 35 amino acids) and serves
to attach both E1 and E3 (mutually exclusively) to the E2 core
in this as in other eicosahedral PDH complexes [2,5,6]. Anal-
ysis of the E1^E2 subcomplex by means of cryo-electron mi-
croscopy reveals the 60 E1 molecules as forming an outer shell
some 90 A? above the surface of the eicosahedral inner core of
60 acetyltransferase domains [4].
The E1 component is a heterodimer (K2L2) with molecular
masses of V41 kDa and V36 kDa for the K- and L-chains,
respectively, and the structure has been solved for the homol-
ogous E1 components of the branched-chain 2-oxo acid de-
hydrogenase (BCDH) complexes of Pseudomonas putida [7]
and Homo sapiens [8]. A crystal structure of the B. stearother-
mophilus E3^PSBD complex has been determined [9], reveal-
ing a single PSBD bound very close to the two-fold axis of the
E3 dimer, as inferred from the 1:1 stoichiometry [5,6]. No
structure of the complex between the PSBD and E1 is avail-
able, but biochemical studies have again demonstrated a 1:1
stoichiometry [6] and that the E1L subunits must contain the
site of association [6,10,11]. Likewise, it has been suggested
that the PSBD-binding site on E1 is located at or close to the
two-fold axis of the K2L2 tetramer [6], where residues in par-
ticular from the C-terminal regions of the L-chains are located
[7,8].
We show here that a plausible molecular model of the
L-subunits in the E1 K2L2 heterotetramer from the B. stearo-
thermophilus PDH complex can be generated, and that this
can then be used to identify amino acid residues whose
side chains play an important part in the interaction with
the PSBD of the E2 chain. In addition, the results throw
light on the protein^protein interaction that underlies the
assembly, in line with recent thermodynamic studies of the
system [12^14].
2. Materials and methods
2.1. Sequence alignments and homology modelling
The amino acid sequence of the E1L chain from the B. stearother-
mophilus PDH complex (residues 1^324 out of 324) was aligned with
the sequences of the E1L chains of the 2-oxoisovalerate decarboxylase
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of P. putida (residues 3^338 out of 339) and humans (residues 19^342
out of 342). SWISS-MODEL (Automated Protein Modeling Server)
was used for this purpose.
The three-dimensional structure of the E1L subunit of the B. stearo-
thermophilus E1 was modelled using the program Swiss-PdbViewer
(http://www.expasy.ch/spdbv/mainpage.htm) [15] connecting to Swiss
Model Automated Protein Modeling Server. Modelling was based on
the two crystal structures of the P. putida and human proteins avail-
able in the database (Protein Data Bank identi¢cation: 1QS0B and
1DTWB). The structures of the E1L subunits were superimposed and
assembled to produce the E1(L2) homodimer using the graphical soft-
ware MidasPlus, in which the CK atoms of residues were used for the
superimposition and assembly.
2.2. Gene manipulation and site-directed mutagenesis
A sub-gene encoding the E1L subunit in the plasmid pKBstE1b [16]
was ampli¢ed by the polymerase chain reaction (PCR). The 33 bp
forward primer incorporated six mismatches to create an XhoI restric-
tion site at the region corresponding to 1400 bp. Primer sequences
used were as follows: 5P-CCCATGCCGAACTCGAGAGTGAAAC-
GCCGTAGC-3P (forward, mismatches underlined) and 5P-GCTA-
CGGCGTTTCACTCTCGAGTTCGGCATGGG-3P (reverse). The
resulting 1197 bp DNA fragment was cut with NcoI and ScaI and
puri¢ed using a Qiagen Plasmid Mini-Kit (Qiagen, Chatsworth, CA,
USA) after electrophoresis in a 10% polyacrylamide gel. This frag-
ment was then ligated into NcoI/ScaI-cut, pKBstE1b expression vec-
tor. The resulting plasmid pKBstE1b(XhoI) was transformed into the
Escherichia coli strain XL1 Blue. The insert DNA was completely
sequenced to ensure its accuracy. This plasmid was used as a template
for site-directed mutagenesis. To create E1L variants, the following
primers were used: 5P end primer: 5P-GGAATACACGATTCCGA-
TCGGCAA-3P ; 3P end primer: 5P-GCTACGGCGTTTCACT-
CTCGAGTTCGGCATGGG-3P ; E251A: 5P-ATCATCGGTTCGGT-
CGCAAAAACGGGC-3P, 5P-GCCCGTTTTTGCGACCGAACCG-
ATGAT-3P ; K252A: 5P-ATCATCGGTTCGGTCGAAGCAACGG-
GC-3P, 5P-GCCCGTTGCTTCGACCGAACCGATGAT-3P ; R255A:
5P-GAAAAAACGGGCGCCGCCATTGTCGTT-3P, 5P-AACGACA-
ATGGCGGCGCCCGTTTTTTC-3P ; E285A: 5P-CATCTTAAGCC-
TTGCGGCGCCGGTGTTGCG-3P, 5P-CGCAACACCGGCGCCGC-
AAGGCTTAAGATG-3P ; M322A: 5P-GCGAAAAAAGTGGCGA-
ACTTCTAACAGCGGAC-3P, 5P-GTCCGCTGTTAGAAGTTCGC-
CACTTTTTTCGC-3P ; N323A: 5P-GCGAAAAAAGTGATGGCC-
TTCTAACAGCGGAC-3P, 5P-GTCCGCTGTTAGAAGGCCATCA-
CTTTTTTCGC-3P ; F324A: 5P-AGTGATGAACGCCTAACAGCG-
GACAA-3P, 5P-TTGTCCGCTGTTAGGCGTTCATCA-3P.
For the D203A mutant, the restriction sites PstI and XhoI were
used for improved cloning e⁄ciency. 5P end primer: 5P-TGCGCT-
GCGTATCGAGTTGAAA-3P (for the PstI restriction site); 3P end
primer: 5P-GCTACGGCGTTTCACTCTCGAGTTCGGCATGGG-3P
(for the XhoI restriction site); D203A: 5P-AAGGAAAAGCCATCA-
CGAT-3P, 5P-ATCGTGATGGCTTTTCCTT-3P.
2.3. Gene expression and protein puri¢cation
Cultures of E. coli strain TG1 recO cells transformed with plasmid
pKBstE1a or pKBstE1b(XhoI) were grown in LB medium and in-
duced with isopropyl-L-D-thiogalactose, and the recombinant
E1(K2L2) protein was puri¢ed as described previously [16]. The purity
of the protein was checked by means of sodium dodecyl sulfate^poly-
acrylamide gel electrophoresis using the Pharmacia PhastSystem1.
The mutation in each protein was con¢rmed by means of electrospray
mass spectrometry using a Micromass Quattro-LC spectrometer.
2.4. Enzymatic activity of mutant E1 components
The enzymatic activity of wild-type and mutant E1 components was
determined by measuring the rate of the reduction of the arti¢cial
electron acceptor 2,6-dichlorophenolindophenol (DCPIP) in the pres-
ence of pyruvate [17]. The decrease in A600 was monitored at a tem-
perature of 30‡C.
2.5. Surface plasmon resonance (SPR) detection
The interaction of the PSBD with the mutant E1 was investigated
by using SPR detection [18]. A di-domain (ThDD: a LD linked to its
PSBD and with a thrombin cleavage site in the linker region) was
puri¢ed and immobilised on the CM5 sensor chip of a Biacore 2000
instrument using the surface thiol method to react with the lipoyl
group on the LD, as described elsewhere [13,18]. The immobilisation
level of the ThDD was adjusted from 100 to 250 response units to
minimise any potential mass transport phenomena. To obtain kinetic
parameters, E1 was injected at a £ow rate of 5 Wl/min to interact with
the sensor surface for 10 min (association phase) at ¢ve di¡erent
concentrations ranging from 12.5 to 200 nM. The £ow was continued
for a further 10 min with E1 omitted from the bu¡er to obtain the
dissociation phase, all as described elsewhere [13,18]. Experimental
data for each mutant were collected from ¢ve runs (sensorgrams).
3. Results and discussion
3.1. Sequence alignment for the B. stearothermophilus E1L
chain
The complete amino acid sequence of the B. stearothermo-
philus E1L chain (residues 1^324) was aligned with the sequen-
ces of E1L chains from P. putida (residues 4^339) and human
(residues 19^342), whose crystal structures have been solved at
Fig. 1. Sequence alignment of B. stearothermophilus E1L with P. putida and human E1L chains. Dark grey, identical residues; light grey, non-
identical but structurally equivalent residues. Proposed secondary structure elements in the B. stearothermophilus E1L structure are indicated
(h, K-helix; s, L-strand). BsE1L, B. stearothermophilus E1L ; PpE1L, P. putida E1L ; HsE1L, human E1L.
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resolutions of 2.4 A? [7] and 2.7 A? [8], respectively. As depicted
in Fig. 1, the B. stearothermophilus and P. putida chains show
44.7% sequence identity, and the B. stearothermophilus and
H. sapiens chains exhibit 45.8% sequence identity. The align-
ment suggests that the B. stearothermophilus E1L monomer
contains 11 K-helices and 14 L-strands.
3.2. Homology modelling of the B. stearothermophilus E1L
monomer
The eicosahedral PDH complex of B. stearothermophilus
and the octahedral BCDH complexes of P. putida and
H. sapiens have a heterotetrameric (K2L2) E1 component. To
create a homology model for the B. stearothermophilus E1L,
Fig. 2. Molscript [23] representation of homology-modelled structures of B. stearothermophilus E1L monomer and dimer. A: CK trace of the
predicted B. stearothermophilus E1L monomer (blue) superimposed on the crystallographically determined structures of P. putida [7] (red) and
human [8] (yellow) E1L monomers. B: Dimer of the E1L subunit constructed by the program MidasPlus. One subunit is depicted in blue and
the other in grey. C: Amino acid residues targeted for alanine-scanning mutagenesis in the B. stearothermophilus E1L dimer. The view looks up
the two-fold axis of the dimer, orthogonal to the view in B. Basic residues are coloured green, acidic residues red and uncharged residues yel-
low. E1 is a tetramer (K2L2) and the K-subunits have been omitted here for convenience and clarity. The K-subunits are thought not to interact
with the PSBD [6]. (For interpretation of the references to color in this ¢gure legend, the reader is referred to the web version of this article.)
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we used the other two proteins as templates. A protein whose
sequence has at least 40% identity to a known template struc-
ture can be modelled automatically with an accuracy ap-
proaching that of a low resolution X-ray structure or a me-
dium resolution nuclear magnetic resonance structure [19,20].
The structure of the E1L monomer was modelled by the pro-
gram SWISS-MODEL (Fig. 2A) and the dimer was con-
structed by graphical software MidasPlus (Fig. 2B). The back-
bone of the model for B. stearothermophilus E1L was closely
superimposable on those of the templates, except for the loop
regions (Fig. 2A). As in the sequence alignments (Fig. 1), the
loop regions of the model structure di¡er from the two crys-
tallographically determined structures at loop 15 (residues
178^195) and loop 19 (residues 237^246). However, these var-
iable regions are highly solvent-exposed and located far from
the two-fold axis of the dimer, which is expected to be at or
close to the potential binding site for the PSBD of E2. There-
fore, these loop regions are unlikely to play a signi¢cant part
in the binding.
The E1L model structure was further analysed by using the
validation software PROCHECK [21] to evaluate its stereo-
chemical quality. A Ramachandran plot (data not shown)
exhibited a good distribution for the P/i angles, consistent
with a good quality model. For the E1L monomer, 82.5% of
(non-Gly and non-Pro) residues were in the most favoured
regions, 15.6% in the additionally allowed regions, 1.1% in
the generously allowed regions, and only 0.7% in the disal-
lowed regions.
3.3. Identi¢cation of the residues in the E1L subunit involved in
binding the PSBD of E2
The positively charged residue Arg135 and the non-polar
residue Met131 of the PSBD appear to be prominently in-
volved in binding E1 to the E2 chain of the B. stearothermo-
philus PDH complex [14]. We therefore searched for nega-
tively charged residues, which might interact with Arg135
and non-polar residues, which might interact with Met131,
among the surface residues on the E1L dimer. The binding
site for PSBD on E1 is likely to be in the E1L chains in the
vicinity of the E1 two-fold axis, where the C-terminal regions
of the E1L chain comprise much of the surface [6^8,10,11]. In
the light of the structure in Fig. 2, two residues with acidic
side chains (Glu251 and Glu285) and one residue with a non-
polar side chain (the C-terminal Phe324) were initially chosen
for replacement with alanine. Other surface residues (Asp203,
Lys252, Arg255, Met322 and Asn323) in the immediate vicin-
ity (within 10 A? ) of the centre of Glu285 were subsequently
replaced with alanine to check their involvement (Fig. 2C).
The e¡ect of the mutations in E1L on the catalytic activity
of the reassembled E1 (K2L2) tetramer was assessed using the
DCPIP reduction assay. The speci¢c activities of almost all
the mutants were found to be roughly the same, if anything a
little higher than that of wild-type E1 (Fig. 3). In order to test
the binding a⁄nity of E1 mutants for the wild-type PSBD,
non-denaturing polyacrylamide gel electrophoresis was carried
out after mixing the PSBD with the reassembled E1 (K2L2)
heterotetramer [6,13]. All the E1 mutants retained their nor-
mal capacity to bind the PSBD under these conditions (data
not shown). Thus, the mutations in the E1L chain appear to
be benign in terms of the overall enzymatic activity and the
folding and assembly of the E1 tetramer, consistent with the
fact that sites of mutation on E1L are located far from the
active site of E1 (K2L2).
SPR analysis was used to measure equilibrium dissociation
constants (Kd) for the interaction of the mutant E1 (K2L2)
tetramers with wild-type PSBD. SPR analysis for E1 mutants
E251A, E285A and F324A was performed ¢rst, followed by
the other mutants: D203A, K252, R255A, M322A and
N323A. For every mutant, wild-type E1 was passed through
the £ow cell and used as an internal reference. The kinetic
Fig. 3. Enzymatic activity of the wild-type and mutant forms of E1.
The speci¢c activities of wild-type E1 and E1 reassembled with mu-
tant E1L chains were determined by means of the DCPIP assay
[17]. Decrease in A600 was monitored at 30‡C.
Table 1
Kinetic and thermodynamic parameters for the interaction of PSBD mutants with E1 mutants
Proteins kon(mut)/kon(wt) koff (mut)/koff (wt) Kd(mut)/Kd(wt) vG (kcal/mol)a
PSBD E1
WT D203A 1.0 1.5 1.5 312.7
WT E251A 1.0 2.4 2.4 312.4
WT K252A 1.0 1.0 1.0 312.9
WT R255A 1.0 3.7 3.7 312.1
WT E285A 1.0 8.6 8.6 311.6
WT M22A 1.0 3.0 3.0 312.2
WT N323A 1.0 2.2 2.2 312.4
WT F324A 1.0 12.6 12.6 311.4
Kinetic data were determined by means of SPR analysis. The errors are less than T 5%.
All the measurements were performed in HBS bu¡er, pH 7.4 and at 25‡C, as in Section 2.
The kinetic parameters of the interaction of the PSBD with E1 are kon = 3.27U106 M31 s31, koff = 1.06U1033 s31, Kd = 3.24U10310 M31 [18].
avG=3RTln Kd, where R=1.987 cal/mol/K and T=298 K.
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parameters were then evaluated as relative ratios (the value
for a mutant divided by that for the wild-type) and are listed
in Table 1.
The E285A and F324A mutations in E1L gave rise to the
biggest e¡ects on the binding a⁄nity. The E1 mutants E285A
and F324A dissociated from the wild-type PSBD about nine-
fold and 13-fold faster, respectively, than wild-type E1. In
contrast, the other mutations displayed little e¡ect on the
binding a⁄nity. These results invite the speculation that
Glu285 and Phe324 may be involved in the interaction with
PSBD and begin to outline the E1L interface in the complex
with PSBD.
3.4. Nature of the binding sites for PSBD on E1 and E3
The electrostatic surface potential was calculated by using
the computer software GRASP [22] and mapped onto the
molecular surfaces of E1, E3 and PSBD (Fig. 4). The electro-
statics and surface shape of the regions around the two-fold
axes of both E1 and E3 were compared. As shown in Fig. 4,
the surface of helix 1 of PSBD is characterised by highly
exposed positively charged residues. In the crystal structure
of the E3^PSBD complex [9], three of these residues,
Arg135, Arg139 and Arg156, generate an ‘electrostatic zipper’
with the negatively charged side chains of Asp344 and Glu431
from one subunit of the E3 dimer and E3 makes a snug ¢t
with this region of the PSBD. The importance of these three
positively charged residues in the PSBD, and in particular of
Arg135, has been highlighted by mutagenesis studies [13]. In
contrast, for E1, three acidic residues, Asp203, Glu251, and
Glu285, protrude from the surface and are evenly distributed
over the likely binding site for PSBD in the C-terminal region
of E1L (Fig. 4). However, only Glu285 appears to be impor-
tant for the binding to PSBD (Table 1). The presence of the
C-terminal residue Phe324, the hydrophobic side chain of
which also projects outwards in this region, should be noted.
It is conceivable that this side chain interacts with the non-
polar side chain of Met131 of the PSBD, a residue of critical
importance in the binding of E1 but not of E3 [14]. A role for
the C-terminal carboxyl group cannot be ruled in or out at
this stage.
The binding of E3 to the PSBD is entropy-driven [12,13],
despite the particular importance of electrostatic interactions
and the loss of con¢gurational entropy [9]. Conversely, E1
binding to the PSBD is more enthalpy-controlled, re£ecting
Fig. 4. Electrostatic surface potential of E1L, E3 and PSBD generated by the program GRASP [22]. Red on the surface indicates a negative
potential, blue a positive potential and white a neutral potential. The electrical scale is from 314 to +9. The structures of the E1L and E3
dimers are viewed looking at the PSBD-binding sites. The closed circles indicate the direction of the two-fold axes and the two triangles repre-
sent protein monomers. Residues whose side chains are involved in binding for E1^PSBD (putative) and for E3^PSBD [9,13] are labelled. (For
interpretation of the references to color in this ¢gure legend, the reader is referred to the web version of this article.)
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a more balanced mixture of hydrophobic and electrostatic
interactions between E1 and PSBD [12,14]. The two di¡erent
binding surfaces between E1 and PSBD, and E3 and PSBD
(Fig. 4), are characterised by substantially di¡erent thermody-
namic parameters but similar kinetics of interaction [12^14].
Two key residues for the E1^PSBD interaction have been
identi¢ed in the present study, and a putative binding site
on E1 delineated at least in part. A full interpretation of the
thermodynamic parameters of the interaction must await the
determination of a three-dimensional structure for the E1^
PSBD complex.
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